TAOK inhibitor 43
CAS No. 850467-66-2
TAOK inhibitor 43( CP 43 | CP43 | CP-43 )
Catalog No. M16175 CAS No. 850467-66-2
TAOK inhibitor 43 is a novel potent, selective, ATP-competitive TAO Kinase (TAOK) inhibitor with IC50 of 11 and 15 nM against TAOK1 and TAOK2, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 58 | Get Quote |
|
| 10MG | 87 | Get Quote |
|
| 25MG | 191 | Get Quote |
|
| 50MG | 356 | Get Quote |
|
| 100MG | 533 | Get Quote |
|
| 500MG | 1152 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTAOK inhibitor 43
-
NoteResearch use only, not for human use.
-
Brief DescriptionTAOK inhibitor 43 is a novel potent, selective, ATP-competitive TAO Kinase (TAOK) inhibitor with IC50 of 11 and 15 nM against TAOK1 and TAOK2, respectively.
-
DescriptionTAOK inhibitor 43 is a novel potent, selective, ATP-competitive TAO Kinase (TAOK) inhibitor with IC50 of 11 and 15 nM against TAOK1 and TAOK2, respectively; increases the mitotic population, the percentages of mitotic cells displaying amplified centrosomes and multipolar spindles, induces cell death, and inhibits cell growth in centrosome-amplified SKBR3 or BT549 breast cancer cell models.
-
In VitroTAO Kinase inhibitor 1 delays mitosis and induces mitotic cell death in centrosome amplified breast cancer cells.
-
In Vivo——
-
SynonymsCP 43 | CP43 | CP-43
-
PathwayMAPK/ERK Signaling
-
TargetMEK
-
RecptorMEK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number850467-66-2
-
Formula Weight384.5
-
Molecular FormulaC25H24N2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (162.56 mM)
-
SMILESO=C(C1=CC=C(C2=CC=CC=C2)C=C1)NCC(NC3CCCC4=C3C=CC=C4)=O
-
Chemical NameN-[2-oxo-2-(1,2,3,4-tetrahydronaphthalen-1-ylamino)ethyl]biphenyl-4-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Koo CY, et al. Mol Cancer Ther. 2017 Nov;16(11):2410-2421.
molnova catalog
related products
-
DLK-IN-14
A potent, selective, CNS penetrant dual leucine zipper kinase (DLK, MAP3K12) inhibitor with Ki of 3 nM.
-
Selumetinib
A highly potent and selective, ATP-uncompetitive inhibitor of MEK1/2 with IC50/Ki of 14.1 nM/22.6 nM for MEK1.
-
Cobimetinib
Cobimetinib (GDC-0973, XL-518) is a potent, selective MEK inhibitor with IC50 of 4.2 nM for MEK1.
Cart
sales@molnova.com